InsidersTradesSigma
Track the IMAGION BIOSYSTEMS LIMITED stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the oversight of ASX. Market capitalisation: €6.4m. The latest transaction was disclosed on 25 August 2026 (Purchase). Among the most active insiders: Robert Romeo Proulx. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
IMAGION BIOSYSTEMS LIMITED is a company listed on the XASX, specializing in the development of medical imaging technologies. It focuses on innovative solutions for the early diagnosis of cancer.